跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tanshinone I
首页
药物
Tanshinone I
Investigational
Small Molecule
Tanshinone I
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
18
H
12
O
3
CAS 编号
568-73-0
UNII ID
03UUH3J385
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Preparation method for tanshinone I
申请人: XI AN HONSON BIOTECHNOLOGY CO
优先权: 2005
CN
Combined application of genistein and tanshinone I
申请人: UNIV YANGZHOU
优先权: 2024
CN
Tanshinone I derivatives and pharmaceutical application thereof
申请人: QIN YINLIN
优先权: 2006
CN
Tanshinone I derivatives and pharmaceutical application thereof
申请人: QIN YINLIN
优先权: 2006
CN
Tanshinone I derivative, preparation method and applications thereof
申请人: SHANGHAI INST MATERIA MEDICA CAS
优先权: 2014
CN
Method for preparing salvianolic acid B, cryptotanshinone, tanshinone I and tanshinone IIA from salviae miltiorrhizae
申请人: JING BRAND CO LTD
优先权: 2020
CN
Application of tanshinone I as specific target NLRP3 inflammasome inhibitor
申请人: THE FIFTH MEDICAL CENTER OF CHINESE PLA GENERAL HOSPITAL
优先权: 2021
CN
Application of tanshinone I to treatment of microglia-mediated disease
申请人: UNIV TIANJIN TRADITIONAL CHINESE MEDICINE
优先权: 2012
CN
药物
反馈